Neuroscience

See-through 'MitoFish' opens a new window on brain diseases

German scientists have demonstrated a new way to investigate mechanisms at work in Alzheimer's and other neurodegenerative diseases, which also could prove useful in the search for effective drugs. For new insights, they ...

Neuroscience

Pedal to the metal: Speeding up treatments for ALS

A therapeutic intervention for amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig's disease, could be on the horizon thanks to unexpected findings by University of Arizona researchers.

Diseases, Conditions, Syndromes

Researchers identify a potential window for treating ALS

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder that affects as many as 30,000 people in the United States, with 5,000 new cases diagnosed each year. It weakens muscles over time, impacting physical function ...

Neuroscience

Amyotrophic lateral sclerosis trial shows novel therapy is safe

An investigational treatment for an inherited form of Lou Gehrig's disease has passed an early phase clinical trial for safety, researchers at Washington University School of Medicine in St. Louis and Massachusetts General ...

Diseases, Conditions, Syndromes

Neurotoxin BMAA found in dust from Great Salt Lake

In a startling discovery, researchers have identified a chronic neurotoxin known as BMAA in dust particles from the Great Salt Lake's dried lakebed. This toxin, linked to neurodegenerative illnesses, has become a significant ...

page 32 from 40